×

Eli Lilly earnings beat

7:20 AM ET Wed, 24 July 2013

John Lechleiter, chairman, president & CEO, Eli Lilly, says they overcame the loss of patents by growing the sales of other products. The company's focus is beginning to turn to autoimmune diseases.